Works in the literature and pan-cancer analyses indicate that PYCR1 is commonly upregulated in various cancers, including kidney adenocarcinoma, gastric cancer, lung cancer, pancreatic ductal adenocarcinoma, renal cell carcinoma, breast cancer, and hepatocellular carcinoma. This evidence concerns the gene PYCR1 and lung carcinoma.